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Abstract 
Infectious bursal disease virus (IBDV) is the etiological agent of an immunosuppressive and highly contagious dis-
ease that affects young birds, thus causing important economic losses in the poultry industry. Multimeric particles 
with different architectures based on the capsid protein VP2 have been widely produced for different purposes. We 
hereby show the production and easy recovery of IBDV subviral particles (SVP) from transiently transformed Nicotiana 
benthamiana. The SVP, which were observed by electronic microscopy, proved to be antigenically and immunogeni-
cally similar to the virion. Indeed, anti-IBDV antibodies from samples of infected birds recognized these SVP and, when 
injected intramuscularly, these subviral particles also evoked a humoral immune response in chickens. We developed 
an in-house ELISA using SVP as coating reagent that demonstrated to be highly accurate and in good agreement with 
a commercial ELISA. This study demonstrates that the recombinant antigen generated and the technology used to 
produce it are suitable for developing a diagnostic tool against Infectious bursal disease.
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Key points
IBDV-SVP are easily recovered from transiently 
transformed Nicotiana benthamiana.
IBDV-SVP maintain the conformational epitopes of 
the virion.
Plant-produced SVP is a reliable antigen to develop 
a highly accurate IBDV ELISA.
Nicotiana benthamiana is a suitable platform to pro-
duce diagnostic reagents.
Introduction
Infectious bursal disease virus (IBDV), a non-enveloped 
virus within the Birnaviridae family, is the etiologi-
cal agent of an immunosuppressive disease that affects 
young chickens. The viral genome is composed of two 
segments of dsRNA, called segment A and B. Segment 
A is expressed as a polyprotein precursor that undergoes 
self-cleavage to release pVP2 (the precursor capsid pro-
tein of 512 residues), VP3 (the scaffolding protein) and 
VP4 (the protease). pVP2 undergoes further processing 
in which cellular and viral proteases and VP2 itself par-
ticipate to yield mature VP2 (441 residues) and several 
C-terminal fragments that remain associated with the 
capsid (Irigoyen et al. 2012). Segment B encodes for VP1, 
the RNA-dependent RNA polymerase.
When segment A is expressed in heterologous systems, 
multimeric particles with different architectures are 
spontaneously assembled (Martinez-Torrecuadrada et al. 
2000a; Caston et  al. 2001). The individual expression of 
VP2-441, or the cleavage processing intermediate VP2-
452 (452 residues), leads to the assembly of icosahedral 
T = 1 subviral particles (SVP) of ~ 23  nm formed by 20 
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trimers of VP2 (Coulibaly et al. 2005; Garriga et al. 2006; 
Doong et al. 2007; Taghavian et al. 2013). The hypervari-
able region of VP2 is contained between the amino acid 
204 and 344 and possesses the conformational epitopes 
that elicit protective immunity and the determinants 
responsible for the interaction with the host cell (Brandt 
et al. 2001; Letzel et al. 2007).
Infectious bursal disease (IBD) occurs worldwide and 
its control depends mainly on accurate vaccination pro-
grams. Regarding IBD diagnosis, the World Organiza-
tion for Animal Health (OIE) recommends the use of 
Enzyme-Linked Immunosorbent Assay (ELISA) for the 
detection of immune responses mainly to monitor vacci-
nation programs (OIE 2018). To date, several ELISA kits 
for IBD are on the market and the most popular kits use 
the whole virus. However, the precursor of VP2 and even 
the neutralizing epitopes expressed in heterologous sys-
tems also perform adequately to detect anti IBDV anti-
bodies (Martinez-Torrecuadrada et  al. 2000b; Sahithi 
et al. 2019).
Plants constitute a competitive platform for the expres-
sion of simple and complex molecules and are suitable for 
the production of virus-like particles (VLP) for human 
and veterinary vaccines (Schillberg et  al. 2019; Rage 
et  al. 2020). VLP are non-infectious particles made of 
viral proteins that mimic virus structure while retaining 
the wild type epitopes. They can display and be carriers 
of auto or heterologous epitopes and, thus, are excellent 
candidates as diagnostic reagents. However, few studies 
have documented the use of plants to produce diagnostic 
reagents for the veterinary field and there are currently 
no plant-derived products on the market.
The objective of this study was to evaluate plants as 
possible hosts for the production of highly conforma-
tional antigens of IBDV that can be used as a high-quality 
reagent in a diagnostic tool for IBDV. The characteriza-
tion included antigenic and immunological assays and 
the subsequent development of an indirect ELISA. 
Although SVP have been produced in bacteria, yeast and 
insect cells (Martinez-Torrecuadrada et al. 2000b; Rogel 
et al. 2003; Dey et al. 2009; Wang et al. 2016), the produc-
tion of IBDV-SVP in plants has remained, to the best of 
our knowledge, unexplored.
Materials and methods
Animals
Embryonated eggs laid by specific-pathogen-free White 
Leghorn hens were purchased from the Instituto Rosen-
busch S.A. (CABA, Argentina) and hatched in an auto-
matic incubator (Yonar, CABA, Argentina). Chickens 
were kept in individual cages with food and water ad libi-
tum. All procedures were performed in agreement with 
institutional guidelines and approved by the Institutional 
Animal Care and Use Committee (C.I.C.U.A.E.—
CICVyA—INTA, Approval no. 66/2015).
Construction of plasmids
The original coding region of the tested VP2 antigen 
(1323 bp, 441 amino acids) was amplified from the VP2 
gene previously cloned (GenBank accession JF965438.1, 
Zanetti et  al. 2012). For this PCR we used the forward 
5′ ACC GGT ATG ACA AAC CTG CAA 3′ and reverse 
5′CTC GAG TTA TGC TCC TGC AATCT3′ primers with 
AgeI and XhoI restriction sites (bold letters), respectively, 
which amplified from position 1 to 1323 bp of the cloned 
VP2 gene. The amplicon was inserted into the pEAQ-HT 
vector (Sainsbury et  al. 2009). The vectors obtained are 
named pEAQ-VP2 and pEAQ-GFP all through the text. 
The plasmids pEAQ-VP2 and pEAQ-GFP (used as con-
trol) were introduced by electroporation into the GV3101 
strain of Agrobacterium tumefaciens. Dr. Lomonossoff of 
the John Innes Centre (Norwich, UK) kindly provided 
pEAQ-HT and pEAQ-HT-GFP vectors.
Agroinfiltration procedure
The recombinant bacteria were cultured in Luria–Bertani 
medium containing 100  µg/mL Kanamycin, 100  µg/mL 
Rifampicin and 50 µg/mL Gentamicin for 16 h at 28  °C 
and then subcultured for 16 h under the same conditions. 
The cultures were pelleted and the obtained bacteria 
were resuspended in an infiltration solution [10 mM MES 
(morpholinoethanesulfonic acid), pH 5.5; 10 mM  MgSO4 
and 100 µM acetosyringone] to an  OD600 of 0.8–1. Infil-
tration of 5 to 6-week-old greenhouse-grown Nicotiana 
benthamiana leaves was performed using a needleless 
syringe. Leaves were harvested 5 days later (Lucero et al. 
2019).
Preparation of SVP
SVP preparation consisted of an adapted protocol based 
on double sucrose cushions (Peyret 2015). Total proteins 
were extracted from 25 g of infiltrated leaves in a blender 
with 3 volumes of chilled buffer containing phosphate-
buffered saline (PBS) pH 7.3, complete EDTA-free pro-
tease inhibition cocktail tablets (ROCHE, cat No. 04 693 
132 001) and 0.04% antifoam O-30 (Sigma Aldrich, St. 
Louis Missouri, USA). The extracts were filtered through 
gauze to clear the sample of gross green material. Clarifi-
cation was performed at 9000×g for 15 min at 4 °C. The 
supernatant was filtered again through a 0.45 µm mem-
brane in a filter device and loaded above 25% (2 mL) and 
70% (0.5 mL) w/v layers of sucrose. Finally, ultracentrifu-
gation was performed at 39,000 rpm in a SW41Ti rotor 
(Beckman) at 4 °C for 2:40 h.
The interface and the bottom fractions were pooled 
and dialyzed against PBS (pH 7.4) in a cold room, using 
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dialysis tubes with a MWCO of 12–14,000. Dialysis 
lasted 39 h and consisted of two buffer changes at 16 and 
23 h. SVP were kept at − 70  °C until use. Once thawed, 
all samples were clarified by centrifugation for 2 min at 
10,000g.
The negative control sample was obtained by infiltrat-
ing leaves with agrobacteria harboring pEAQ-GFP. This 
control underwent the same protocol described above.
Detection and quantification of protein forming SVP
The amount of VP2 present in SVP was estimated against 
a bovine serum albumin (BSA) calibration curve. Briefly, 
12  µL of two-fold serial dilutions of BSA (from 250 to 
7.8 µg/mL) were loaded and resolved in a 12% SDS-PAGE 
along with 12  µL of the sample of interest. All samples 
were analyzed in triplicate. The gel was stained with 
Coomassie Blue reagent for 40  min and the resolved 
bands were analyzed with Gel-Pro Analyzer software 
v3.1. Western blot was performed using rabbit anti-VP2 
antibody diluted 1:500 in PBS-0.05% Tween 20 (Gómez 
et  al. 2013). The positive control used for Western blot 
was a crude extract of plants expressing VP2.
TEM
Samples from the obtained dialysates were loaded onto 
a copper grid and stained with 2% phosphotungstic acid. 
The grids were observed under an electronic microscope 
(CM 200, PHILIPS) at 160 kV. Image acquisition was per-
formed with OLYMPUS iTEM software.
Stability of plant‑derived SVP
Aliquots of SVP were subjected to different temperature 
conditions: 4 °C, 37 °C and room temperature for 1, 2, 7, 
30, or 60  days and then analyzed by ELISA. Stability at 
37 °C was monitored for 30 days.
Immunological characterization
Five 19-day old chickens were vaccinated in a prime/
boost scheme with 60 µg of SVP or the control sample, 
by intramuscular route (IM) in the leg muscle. Both anti-
gens were formulated in Freund’s Complete and Incom-
plete Adjuvants in the prime and boost inoculations, 
respectively. Chickens were vaccinated at 0 and 23 days 
and bled by the wing vein at 0, 14, 23, 30, 43 and 51 days 
post-inoculation.
Serum samples of the vaccinated chickens were evalu-
ated for the presence of specific antibodies against IBDV 
with the commercial IDEXX IBD Ab Test (IDEXX Labo-
ratories, Inc., USA). Titers above 396 were considered 
positive as stated in the manufacturer’s instructions.
Optimal working dilutions of recombinant antigen, 
primary, and secondary antibodies
First, the optimal concentration of plant-derived SVP 
was determined by titration with positive and negative 
sera for IBDV obtained from vaccinated and healthy 
chickens from our animal facility. Briefly, 96-well plates 
(Maxisorp Nunc) were coated with two-fold serial 
dilutions of SVP in 0.1  M bicarbonate buffer, pH 9.6, 
overnight at 4  °C. The plate was blocked with 5% skim 
milk in PBST-ENS (0.05% Tween 20, 5% equine normal 
serum) and subsequently incubated with anti-IBDV 
and negative serum diluted 1:100 as primary antibod-
ies and 1:3000 goat anti-chicken IgG antibody coupled 
to horseradish peroxidase (Bethyl Laboratories Inc cat. 
# A30-106P). The detection step was performed with 
 H2O2/ABTS [2,2′-azinobis (3-ethylbenzthiazoline-
6-sulfonic acid) diammonium salt] substrate/chro-
mogen system in citric acid buffer, pH 5. Reading was 
carried out at 405  nm after 30  min of incubation or 
once the anti-IBDV serum of each plate (positive con-
trol) reached the admission rank of absorbance previ-
ously determined (Mean OD value = 0.84–1.07).
The best combination between primary and conju-
gated antibodies was determined performing a check-
erboard titration. This titration consisted of testing 
1:50, 1:100, 1:200, 1:300, 1:400 and 1:500 dilutions of 
the anti-IBDV antibody and 1:3000, 1:4000, 1:5000 
and 1:6000 dilutions of the anti-chicken conjugated to 
peroxidase.
Cut‑off value and accuracy measures from ROC analysis
A total of 432 reference sera of chickens classified as 
true negatives (192 samples) and true positives (240 
samples) for IBDV using the commercial IDEXX IBD 
Ab Test (IDEXX Laboratories, Inc.) were used for ROC 
analysis of the in-house ELISA-SVP. True positive sera 
belonged to animals naturally infected or vaccinated 
from our animal facility or commercial farms. Negative 
sera came from animals used in past experiments in 
our lab. The method based on the sensitivity–specific-
ity (Se–Sp) equality criterion was used to compute the 
optimal cut-off point. The concordance between meth-
ods to properly classify the samples as positive or nega-
tive was estimated by the calculation of the Weighted 
Cohen’s kappa coefficient (k test) using a panel of 144 
new sera. Values of k test from 0.41 to 0.60 indicate 
moderate agreement; values from 0.61 to 0.80, substan-
tial agreement, and values from 0.81 to 0.99, almost 
perfect agreement (Viera and Garrett 2005). The analy-
ses were done using R 3.4.1 (R Core Team 2017), the 
OptimalCutpoints, and the DescTool packages (López 
Ratón et al. 2014; Signorell 2019).
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Results
Production and preparation of SVP
To achieve the production of SVP in Nicotiana bentha-
miana, we used pEAQ-HT vectors known to give high 
levels of expression or accumulation of recombinant 
protein in plants, and a simple method of purification 
consisting in ultracentrifugation followed by dialysis. 
All steps of the purification procedure [crude extract, 
sucrose supernatant, interface, bottom fraction (70% 
sucrose fraction) and dialysate] were analyzed by SDS-
PAGE and immunoblotting using an anti VP2 antibody 
to visualize the recombinant protein. As expected, 
all samples presented a specific band of the expected 
molecular weight, which would correspond to the mon-
omer of VP2 (~ 42 kDa; Fig. 1a), except for the negative 
control.
It is worth mentioning that dialysis and clarification 
steps helped us to eliminate most contaminants from 
the pooled sample (Fig.  1b), an unexpected but desir-
able effect. The method applied here to obtain the par-
ticles allowed the retrieval of ~ 7  mL of sample and a 
recovery of 56 µg VP2/mg of fresh tissue according to 
the BSA curve (Fig. 1c).
Furthermore, particles of spherical shape and 
homogeneous size with a diameter of approximately 
19.8 ± 1.76  nm were present in the dialysate as evi-
denced by the electronic microscopy (Fig. 1d).
Immunological properties of the SVP
In order to study the immunogenicity of the particles, 
we conducted a vaccination experiment (see “Mate-
rials and methods”). Animals vaccinated with SVP 
developed a humoral response as soon as 14 dpi, which 
became higher after the boost, as evidenced by the 
increase of antibody titers throughout the experiment 
(Fig. 2). As expected, chickens vaccinated with the con-
trol sample showed no anti-IBDV antibodies.
The results indicate that the particles maintain the 
conformational epitopes present in the virion as they 
can elicit anti-IBDV antibodies.
ELISA‑SVP
To determine whether plants can be a suitable platform 
to produce diagnostic reagents for IBDV, we estab-
lished the conditions of an indirect ELISA using SVP 
as antigen, and then compared the results of the ELISA 
with those of a commercial test. The analysis showed 
that 95  ng per well of the SVP (1.9  µg/mL, Fig.  3a) 
along with 1:400 dilution for the anti-IBDV and 1:4000 
dilution for the conjugated antibodies (Fig. 3b) turned 
out to be the optimal dilutions to give maximum sig-
nal, minimum background, and a cost-effective assay. 
The signals of the negative control serum as well as the 
blank of reaction were very low, as expected.
In addition, boiling SVP before coating the plate pro-
duced a drastic decrease in the absorbance (Fig. 3a). This 
finding suggests that the conformational epitopes of the 
SVP were seriously damaged by this procedure. This 
result gives more evidence of the presence of conforma-
tional epitopes and is consistent with the fact that SVP 
triggers an anti-IBDV antibody response (Fig. 2).
Once the ELISA-SVP conditions were defined, we 
analyzed 432 reference sera to calculate the accuracy 
measures of the ELISA-SVP (Table  1) taking the com-
mercial ELISA as reference and obtained the cut-off val-
ues (Fig.  4) suggested by ROC analysis using the Se–Sp 
equality criterion. The area under the ROC curve (AUC) 
results from plotting the coordinates (Se; 1 − Sp) for all 
possible cut-off points. The AUC takes values ranging 
from 0.5 (uninformative test) to 1 (perfect test). Here, the 
AUC and confidence interval obtained was 0.991 (0.981–
1.001); which implies that the ELISA-SVP displays almost 
perfect ability to discriminate negative from positive sera 
samples. Two cut-off values (0.249 and 0.276) accom-
plished the condition of Se equal to Sp. For both cut-off 
values, most of the samples (97%) correctly classified as 
positive. Likewise, the same percentage correctly classi-
fied as negative. The cut-off value of 0.276 resulted in 8 
false negatives, whereas the cut-off value of 0.249 gave 7 
false negatives.
The analysis of concordance for both cutoff values, 
0.249 and 0.276, gave a Kappa value of 0.95 (0.88–1.02) 
and 0.92 (0.84–1.01), respectively, with 144 new sera; 
which implies an almost perfect agreement between 
them. Therefore, any of the cut-off values could be used 
in the ELISA-SVP.
SVP stability
The performance of SVP as an antigen for the ELISA-
SVP, subjected to different conditions, was assessed. Ali-
quots of SVP were incubated at different temperature for 
1, 2, 7, 30 or 60 days before tested. Stability at 37 °C was 
monitored for 30  days. The results indicated that SVP 
conserved the epitopes for antibody recognition after 
incubation at 4 °C, 37 °C or room temperature for several 
days (Fig. 5).
Discussion
The use of plants as bioreactors to produce valuable mol-
ecules has been well documented. Its rationale relies on 
scalability, cost-effectiveness, and time saving; which 
turns plant expression systems into an attractive and 
suitable platform. Expression of complex molecules is 
also feasible in plants (Scotti and Rybicki 2013; Catrice 
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and Sainsbury 2015; Peyret et al. 2015; Rybicki 2019) and 
therefore it was our system of choice.
We demonstrated that the recovery of subviral par-
ticles from transiently transformed plants is possible 
through a simple method (sucrose cushion followed by 
dialysis). To our knowledge, this is the first study showing 
the production and recovery of IBDV subviral parti-
cles from a model plant (N. benthamiana). We detected 
spherical particles of homogeneous size of approximately 
19.8 ± 1.76 by electronic microscopy (Fig. 1d). Although 
smaller than the SVP produced in other expression sys-
tems like ~ 23  nm SVP derived from yeast (Taghavian 
Fig. 1 Expression, semipurification, and quantification of SVP. Aliquots of the subsequent steps of the purification of the samples were loaded 
into 12% SDS-PAGE for a immunoblotting and b Coomassie blue staining. VP2 were identified using a rabbit anti-VP2 antibody diluted 1:500. The 
negative control consisted of leaves infiltrated with GFP subjected to the same purification process (see “Materials and methods”). c Standard 
curve of BSA—250, 125, 62.5, 31.25, 15.6 and 7.8 µg/mL—and VP2 were stained with Coomassie blue reagent and the intensity of the bands were 
analyzed with Gel-Pro Analyzer software v3.1. d Transmission electron micrographs of SVP. The dialysate was subjected to negative staining with 2% 
phosphotungstic acid and observed under an electronic microscope (CM 200, PHILIPS). Scale bar of large pictures = 200 nm
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et al. 2013; Wang et al. 2016) and insect cells (Martinez-
Torrecuadrada et al. 2003), these plant-derived SVP con-
served the antigenic and the immunogenic properties. 
Difference in size could arise from the measurement 
tools used among the different studies. A dynamic light 
scattering analysis may be more appropriate for assessing 
the exact size of purified plant-derived SVP.
On the other hand, the few steps in the recovery pro-
cess seem to be sufficient to remove the bulk of the impu-
rities of the sample (Fig. 1a, b). In addition, the in-house 
ELISA results suggest that further steps of purification 
would be unnecessary. Indeed, negative sera of chicken 
were unreactive with the dialysate (SVP) (Fig.  3a) and 
false positives are extremely low when considering the 
cut-off values suggested by ROC curves (Table 1).
Several researchers have described the immuno-
genicity of SVP (Martinez-Torrecuadrada et  al. 2003; 
Taghavian et al. 2013; Wang et al. 2016). Ho and cow-
orkers reported the capsid formation and immunogenic 
properties of deleted variants in amino acid residues 
at the N- or C-terminal region of VP2-452 produced 
in insect cells (Ho et al. 2010). That study showed that 
both VP2-452H and VP2-441H (VP2 with a His-tag at 
the c terminal) yielded similar amounts of recombinant 
proteins. We also performed the expression of VP2-452 
in N. benthamiana and studied the expression kinetic 
as explained in materials and methods, but the expres-
sion levels turned out to be considerably lower than 
those of VP2-441 (unpublished results). From our and 
others’ experiences, the level of recombinant protein is 
critical to be able to observe SVPs by electronic micros-
copy. For this reason, we used pEAQ-HT vector and, 
furthermore, chose mature VP2-441 to obtain the SVP. 
The results obtained in chickens herein presented agree 
with those observed by other researchers. Indeed, the 
results indicate that N. benthamiana-derived SVP also 
conserved the highly conformational epitopes, suggest-
ing that this model plant can be not only a production 
platform for IBDV antigens but also a vaccine platform 
for IBD control.
The results from the assessment of the performance 
of plant-derived SVP as antigen for an ELISA kit 
revealed that the best temperature to store the SVP is 
4 °C, although it is also very stable at room temperature. 
Fig. 2 Humoral immune response elicited by SVP. Nineteen-day-old 
chickens were immunized with SVP (closed circles) or control sample 
(open circles) on days 0 and 23 and bled at 0, 14, 23, 30, 43, and 
51 days post-inoculation. Sera were evaluated for the presence 
of specific antibodies against IBDV with a commercial kit (IDEXX 
Laboratories, Inc., USA). Titres above 396 were considered positive 
as indicated by the manufacturer’s instructions (dashed line). Black 
lines indicate the mean of the antibody titre. Arrow indicates boost 
vaccination
a
b
Fig. 3 Titration of the ELISA-SVP reagents. a Antigen titration. Serial 
two-fold dilutions of boiled (circles) and non-boiled SVP (triangles) 
were titrated using 1:100 anti-IBDV and negative serum (open 
symbols). Anti-chicken antibody conjugated to peroxidase was used 
in dilution 1:3000. SVP were boiled for 3 min and then assayed. b 
Checkerboard titration between primary and conjugate antibodies. 
Polyclonal sera anti-IBDV diluted 1:50 to 1:500 and anti-chicken HRP 
diluted 1:3000 to 1:6000 were assayed using SVP (curves with closed 
symbols) or control sample (curves with open symbols). The arrow 
indicates the working dilutions of choice
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Rani and Kumar (2015) demonstrated that IBDV sub-
jected to different temperatures for 2 h lost infectivity 
at 56  °C. This finding suggests that high temperatures 
might affect the conformation of the capsids (at least 
the sites responsible for interaction with cell surface 
receptor), although protein mass remained unaltered 
even at 72 °C (Rani and Kumar 2015). In another study, 
purified SVP produced in yeast were resistant to tem-
peratures between 25 and 60 °C for 1 h, as no precipi-
tation or apparent conformational changes occurred 
(Taghavian et  al. 2012). In our study, plant-derived 
SVP were stable at room temperature and at 37  °C for 
Table 1 Accuracy measures and ROC analysis for the ELISA-SVP based on Sp and Se equal criterion
Se sensitivity, Sp specificity, PPV positive predictive value, NPV negative predictive value, FP false positive, FN false negative, AUC area under the ROC curve, CI 
confidence interval
Cut off 0.25 Cut off 0.28 ROC analysis
0.95 CI 0.95 CI AUC 0.95 CI Correctly classified
Se 0.97 0.94–0.99 0.97 0.93–0.99 0.991 0.981–1.001 99%
Sp 0.97 0.93–0.99 0.97 0.93–0.99
PPV 0.97 0.94–0.99 0.97 0.94–0.99
NPV 0.96 0.93–0.99 0.96 0.92–0.99
FP 6 6
FN 7 8
Fig. 4 Graphical analysis of the cut off value, Se and Sp for the ELISA-SVP. a ROC curve. Numbers in brackets in the upper left corner corresponds 
to 1 minus Sp and Se values for the resulting cutoffs. b Cut off values obtained using Se = Sp criterion. The optimal criterion refers to the Se–Sp 
difference at the optimal cutoff. c Dot diagram for the 432 reference samples, 240 positives (code = 1), and 192 negatives (code = 0) analyzed with 
the in-house ELISA-SVP. The lines represent the cut off values (0.249 and 0.276 OD values). d Sensitivity and specificity plots according to cutpoints
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at least 30  days. Therefore, SVP are not only resistant 
to high temperatures, as reported before, but also for 
long periods. In addition, in the previous reports and in 
our study, the solubility of the protein was completely 
lost with boiling. Further studies of accelerated stability 
(at 37  °C) and stability in working conditions (at 4  °C) 
with a pilot batch made of raw materials of choice, such 
as plastic and preservatives, should be performed to 
determine the optimal temperature of storage and expi-
ration date.
Altogether, we demonstrated that SVP conserved the 
epitopes responsible for the interaction with anti-IBDV 
antibodies at cold or at room temperature in PBS, which 
is a very attractive feature for an antigen intended to be 
used in an ELISA kit.
In a previous study, the researchers of two different 
groups reported optimal SVP concentrations of 0.5–
1.5 µg/well or 1 µg/mL to be used in an in-house ELISA 
(Martinez-Torrecuadrada et  al. 2000b; Dey et  al. 2009). 
Similarly, in this study, the optimal concentration was 
95 ng/well, which corresponds to 1.9 µg/mL, of the plant-
derived antigen. Therefore, our findings agree with those 
expected for recombinant SVP.
Finally, we tested its performance in comparison with 
the ELISA IDEXX, one of the most popular commercial 
ELISA kits used for the detection of anti-IBDV anti-
bodies. The cut-offs suggested by the ROC curves had 
a 97% of specificity and a 97% of sensitivity associated 
and an AUC of 0.99. This means that the ELISA-SVP 
will correctly classify samples in 99 out of 100 times, 
thus indicating high accuracy of the tests. Kappa test 
using either of the obtained cut-offs also indicated a 
good force of agreement between tests (k > 0.9). It is 
worth mentioning that a third serological test could be 
applied to classify the discordant samples.
The use of the recombinant antigen proposed in this 
study avoids the manipulation, amplification (e.g. in 
eggs or in cell culture) and purification of an infectious 
agent and furthermore decreases the costs associated 
to these processes. In addition, both ELISAs performed 
well suggesting that the recombinant ELISA-SVP could 
replace the commonly used test.
We demonstrated that N. benthamiana is a suitable 
platform for producing efficiently assembled IBD SVP 
that conserve antigenic and immunogenic properties. 
We also showed that a simple method of semipurifica-
tion is enough to recover recombinant subviral parti-
cles from leaves and that these particles, in turn, can be 
used as a reliable antigen for an ELISA kit. Therefore, 
this plant-derived technology has great potential as a 
platform for producing diagnostic tools for infectious 
bursal disease.
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